Healthcare professionals / Gastroenterology / EXALTTM Model D Single-Use Duodenoscope / Infection Prevention


Duodenoscope reprocessing is in a state of transition. The environment, equipment, and guidelines that inform cleaning procedures are constantly changing to address safety concerns and reduce the risk of contamination and infection.

Endoscope Reprocessing & Technology Advances in ERCP for the Practicing Gastroenterologist

Thursday, August 6th at 7:30 - 8:30 PM ET

Live webcast discussing the history of duodenoscope cross-contamination, FDA recommendations and new technologies.

Register Now

Duodenoscope reprocessing and safety communications

There have been more FDA safety communications on duodenoscopes than any other medical device since 2013.

EXALT safety graphic

Subsequently the FDA mandated post market surveillance studies to monitor the effectiveness of reprocessing.

Interim Results*

EXALT timeline graphic
Up to 5.0% of properly collected samples tested positive for high-concern organisms, which cause diseases
Up to 4.4% of properly collected samples tested positive for enough low concern organisms to indicate a reprocessing failure
*Data reflects the July 2019 interim data posted on the FDA 522 Post-market Surveillance Studies websites for the Sampling and Culture Studies performed by Olympus, Pentax and Fujifilm. These numbers may change as additional interim results become available or a final report is issued.  Olympus 522 site : Fujifim 522 site:  Pentax:

Are you familiar with the difference between a fully single-use duodenoscope and new technologies utilizing single-use endcaps?